My NCBI | Sign In
RSS Settings
  • Search: Cozzi-Lepri Alessandro[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 42

    1.

    Development of a didanosine genotypic resistance interpretation system based on large derivation and validation datasets.

    Assoumou L, Cozzi-Lepri A, Brun-Vézinet F, Degruttola V, Kuritzkes DR, Phillips A, Zolopa A, Miller V, Flandre P, Costagliola D; on behalf of the Standardization, Clinical Relevance of HIV Drug Resistance Testing Project from the Forum for Collaborative HIV Research.

    AIDS. 2009 Oct 27. [Epub ahead of print]PMID: 19864933 [PubMed - as supplied by publisher]Related articles

    2.

    Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings.

    Cozzi-Lepri A, Phillips AN, Martinez-Picado J, Monforte A, Katlama C, Eg Hansen AB, Horban A, Bruun J, Clotet B, Lundgren JD; EuroSIDA Study Group.

    J Infect Dis. 2009 Sep 1;200(5):687-97.PMID: 19604043 [PubMed - indexed for MEDLINE]Related articles

    3.

    Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.

    d'Arminio Monforte A, Cozzi-Lepri A, Castagna A, Antinori A, De Luca A, Mussini C, Caputo SL, Arlotti M, Magnani G, Pellizzer G, Maggiolo F, Puoti M; Icona Foundation Study Group.

    Clin Infect Dis. 2009 Aug 15;49(4):612-22.PMID: 19591597 [PubMed - indexed for MEDLINE]Related articles

    4.

    Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis.

    Gupta RK, Hill A, Sawyer AW, Cozzi-Lepri A, von Wyl V, Yerly S, Lima VD, Günthard HF, Gilks C, Pillay D.

    Lancet Infect Dis. 2009 Jul;9(7):409-17.PMID: 19555900 [PubMed - indexed for MEDLINE]Related articles

    5.

    Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.

    Cozzi-Lepri A, Phillips AN, Clotet B, Mocroft A, Ruiz L, Kirk O, Lazzarin A, Wiercinska-Drapalo A, Karlsson A, Lundgren JD; EuroSIDA Study Group.

    AIDS. 2008 Oct 18;22(16):2187-98.PMID: 18832882 [PubMed - indexed for MEDLINE]Related articles

    6.

    Initiatives for developing and comparing genotype interpretation systems: external validation of existing systems for didanosine against virological response.

    Assoumou L, Brun-Vézinet F, Cozzi-Lepri A, Kuritzkes D, Phillips A, Zolopa A, Degruttola V, Miller V, Costagliola D; Standardization and Clinical Relevance of HIV Drug Resistance Testing Project of the Forum for Collaborative HIV Research.

    J Infect Dis. 2008 Aug 15;198(4):470-80.PMID: 18598191 [PubMed - indexed for MEDLINE]Related articles

    7.

    Modelled in vivo HIV fitness under drug selective pressure and estimated genetic barrier towards resistance are predictive for virological response.

    Deforche K, Cozzi-Lepri A, Theys K, Clotet B, Camacho RJ, Kjaer J, Van Laethem K, Phillips A, Moreau Y, Lundgren JD, Vandamme AM; EuroSIDA Study Group.

    Antivir Ther. 2008;13(3):399-407.PMID: 18572753 [PubMed - indexed for MEDLINE]Related articles

    8.

    Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA Study.

    Bannister WP, Cozzi-Lepri A, Clotet B, Mocroft A, Kjaer J, Reiss P, von Wyl V, Lazzarin A, Katlama C, Phillips AN, Ruiz L, Lundgren JD; EuroSIDA study group.

    J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):324-33.PMID: 18545152 [PubMed - indexed for MEDLINE]Related articles

    9.

    Self-reported sexual dysfunction is frequent among HIV-infected persons and is associated with suboptimal adherence to antiretrovirals.

    Trotta MP, Ammassari A, Murri R, Marconi P, Zaccarelli M, Cozzi-Lepri A, Acinapura R, Abrescia N, De Longis P, Tozzi V, Scalzini A, Vullo V, Boumis E, Nasta P, Monforte A, Antinori A; AdICoNA and AdeSpall Study Group.

    AIDS Patient Care STDS. 2008 Apr;22(4):291-9.PMID: 18422461 [PubMed - indexed for MEDLINE]Related articles

    10.

    Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA.

    Bannister WP, Ruiz L, Cozzi-Lepri A, Mocroft A, Kirk O, Staszewski S, Loveday C, Karlsson A, Monforte A, Clotet B, Lundgren JD; EuroSIDA study group.

    AIDS. 2008 Jan 30;22(3):367-76.PMID: 18195563 [PubMed - indexed for MEDLINE]Related articles

    11.

    Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patients.

    Ceccherini-Silberstein F, Cozzi-Lepri A, Ruiz L, Mocroft A, Phillips AN, Olsen CH, Gatell JM, Gunthard HF, Reiss P, Perno CF, Clotet B, Lundgren JD; EuroSIDA Study Group.

    J Infect Dis. 2007 Oct 15;196(8):1180-90. Epub 2007 Sep 19.PMID: 17955437 [PubMed - indexed for MEDLINE]Related articles

    12.

    A whole-genome association study of major determinants for host control of HIV-1.

    Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, Zhang K, Gumbs C, Castagna A, Cossarizza A, Cozzi-Lepri A, De Luca A, Easterbrook P, Francioli P, Mallal S, Martinez-Picado J, Miro JM, Obel N, Smith JP, Wyniger J, Descombes P, Antonarakis SE, Letvin NL, McMichael AJ, Haynes BF, Telenti A, Goldstein DB.

    Science. 2007 Aug 17;317(5840):944-7. Epub 2007 Jul 19.PMID: 17641165 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen.

    Cozzi-Lepri A, Phillips AN, Ruiz L, Clotet B, Loveday C, Kjaer J, Mens H, Clumeck N, Viksna L, Antunes F, Machala L, Lundgren JD; EuroSIDA Study Group.

    AIDS. 2007 Mar 30;21(6):721-32.PMID: 17413693 [PubMed - indexed for MEDLINE]Related articles

    14.

    Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?

    Cicconi P, Cozzi-Lepri A, Phillips A, Puoti M, Antonucci G, Manconi PE, Tositti G, Colangeli V, Lichtner M, Monforte A; ICoNA Study Group.

    AIDS. 2007 Mar 12;21(5):599-606.PMID: 17314522 [PubMed - indexed for MEDLINE]Related articles

    15.

    Significant link between sCD30 changes and HIV viremia in patients treated with HAART.

    Biswas P, Cozzi-Lepri A, Delfanti F, Galli A, Colangeli V, Moioli MC, Scarchilli A, Abrescia N, Vigevani G, D'Arminio-Monforte A, Novati R, Lazzarin A.

    J Med Virol. 2006 Dec;78(12):1513-9.PMID: 17063513 [PubMed - indexed for MEDLINE]Related articles

    16.

    Lopinavir/ritonavir or efavirenz plus two nucleoside analogues as first-line antiretroviral therapy: a non-randomized comparison.

    De Luca A, Cozzi-Lepri A, Antinori A, Zaccarelli M, Bongiovanni M, Di Giambenedetto S, Marconi P, Cicconi P, Resta F, Grisorio B, Ciardi M, Cauda R, Monforte A; I.Co.N.A; UCSC; IMIT-MI; INMI.

    Antivir Ther. 2006;11(5):609-18.PMID: 16964829 [PubMed - indexed for MEDLINE]Related articles

    17.

    Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals: results from an inter-cohort analysis.

    Puoti M, Cozzi-Lepri A, Paraninfo G, Arici C, Moller NF, Lundgren JD, Ledergerber B, Rickenbach M, Suarez-Lozano I, Garrido M, Dabis F, Winnock M, Milazzo L, Gervais A, Raffi F, Gill J, Rockstroh J, Ourishi N, Mussini C, Castagna A, De Luca A, Monforte A; HBV-HIV International Intercohort Study Group.

    Antivir Ther. 2006;11(5):567-74. Erratum in: Antivir Ther. 2006;11(6):831. Paraninfo, Giuseppe [added]. PMID: 16964824 [PubMed - indexed for MEDLINE]Related articles

    18.

    A comparison between abacavir and efavirenz as the third drug used in combination with a background therapy regimen of 2 nucleoside reverse-transcriptase inhibitors in patients with initially suppressed viral loads.

    Cozzi-Lepri A, De Luca A, Phillips AN, Bongiovanni M, Di Giambenedetto S, Mena M, Moioli MC, Arlotti M, Sighinolfi L, Narciso P, Lichtner M, Cauda R, Monforte A; ICoNA Study Group; UCSC-Roma HIV Cohort Study Group; IMIT Study Group.

    J Infect Dis. 2006 Jul 1;194(1):20-8. Epub 2006 May 16.PMID: 16741878 [PubMed - indexed for MEDLINE]Related articles

    19.

    Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy.

    Solmone M, Girardi E, Lalle E, Abbate I, D'Arminio Monforte A, Cozzi-Lepri A, Alessandrini A, Piscopo R, Ebo F, Cosco L, Antonucci G, Ippolito G, Capobianchi MR; Hepal.Co.N.A. Study Group; I.Co.N.A Study Group.

    Antivir Ther. 2006;11(1):87-94.PMID: 16518964 [PubMed - indexed for MEDLINE]Related articles

    20.

    Multiple viral infections.

    Gaeta GB, Precone DF, Cozzi-Lepri A, Cicconi P, D'Arminio Monforte A.

    J Hepatol. 2006;44(1 Suppl):S108-13. Epub 2005 Nov 28. Review.PMID: 16352369 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    1 free full-text article in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity